- Report
- December 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- December 2024
- 206 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- December 2024
- 186 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- May 2024
- 170 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2025
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- August 2024
- 130 Pages
North America
From €3818EUR$4,000USD£3,199GBP
- Report
- November 2022
- 270 Pages
Global
From €5630EUR$5,899USD£4,717GBP
- Report
- March 2024
- 373 Pages
Global
From €5374EUR$5,827USD£4,350GBP
- Report
- November 2023
- 88 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- November 2023
- 1800 Pages
Global
From €4867EUR$5,100USD£4,078GBP
- Report
- September 2023
- 75 Pages
Global
From €3149EUR$3,300USD£2,639GBP
- Report
- October 2021
- 180 Pages
Global
From €2291EUR$2,400USD£1,919GBP
- Report
- January 2024
- 483 Pages
Global
From €6824EUR$7,150USD£5,717GBP
- Report
- November 2023
- 70 Pages
United States
From €1432EUR$1,500USD£1,199GBP
- Report
- November 2022
- 276 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- June 2021
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- December 2023
- 115 Pages
Global
From €4295EUR$4,500USD£3,598GBP

Early Phase Studies are a critical part of the drug discovery process. They are the first step in the clinical development of a drug, and involve the testing of a drug's safety, efficacy, and pharmacokinetics in humans. Early Phase Studies are typically conducted in small groups of healthy volunteers or patients, and involve the administration of a single dose or multiple doses of the drug. The results of these studies are used to determine whether the drug is safe and effective for further clinical development.
Early Phase Studies are conducted by a variety of companies, including contract research organizations (CROs), pharmaceutical companies, and biotechnology companies. These companies provide services such as clinical trial design, data management, and regulatory support. They also provide expertise in drug development, clinical trial management, and regulatory compliance.
Some of the companies in the Early Phase Study market include Parexel, Quintiles, Covance, PPD, ICON, and Syneos Health. Show Less Read more